Consolidated Statements of Cash Flows (USD $)	12 Months Ended		13 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2012
CASH FLOWS FROM OPERATING ACTIVITIES
Consolidated net loss	$ (26,182,952)	$ (889,071)	$ (27,072,023)
Adjustments to reconcile consolidated net loss to cash used in operating activities:
Stock compensation expense	3,422,182	86,494	3,508,676
Noncash stock expense associated with in-licensing agreement	16,578,000	297,000	16,875,000
Impairment of in-process research and development	1,104,700	0	1,104,700
Depreciation	235	0	235
Change in fair value and accrued interest of notes payable	(815,699)	0	(815,699)
Changes in assets and liabilities, net of effects of acquisition:
(Increase) decrease in other current assets	(1,932,710)	3,593	(1,929,117)
Increase in accounts payable and accrued expenses	595,757	408,310	1,004,067
Increase in interest payable	61,571	7,097	68,668
Increase in deferred revenue	1,980,952	0	1,980,952
Net cash used in operating activities	(5,187,964)	(86,577)	(5,274,541)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchases of property, plant and equipment	(1,399)	0	(1,399)
Cash acquired in connection with acquisition	0	10,386	10,386
Net cash (used in) provided by investing activities	(1,399)	10,386	8,987
CASH FLOWS FROM FINANCING ACTIVITIES
Payments of short-term loans	(200,001)	0	(200,001)
Proceeds from sale of common stock, net	0	9,824,682	9,824,682
Proceeds from sale of preferred stock, net	12,257,309	0	12,257,309
Offering costs paid	(75,903)	0	(75,903)
Purchase of treasury stock	(84,538)	0	(84,538)
Net cash provided by financing activities	11,896,867	9,824,682	21,721,549
NET INCREASE IN CASH AND CASH EQUIVALENTS	6,707,504	9,748,491	16,455,955
Cash and cash equivalents at beginning of year	9,748,491	0	0
CASH AND CASH EQUIVALENTS AT END OF YEAR	16,455,995	9,748,491	16,455,995
NONCASH TRANSACTIONS
Conversion of notes payable to preferred stock	0	55,271	55,271
Accrued financing costs	$ 0	$ 61,138	$ 61,138